See more : Aspo Oyj (ASPO.HE) Income Statement Analysis – Financial Results
Complete financial analysis of Global Medical REIT Inc. (GMRE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Global Medical REIT Inc., a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
- Shinelong Automotive Lightweight Application Limited (1930.HK) Income Statement Analysis – Financial Results
- OSRAM Licht AG (OSR.DE) Income Statement Analysis – Financial Results
- InnoCare Pharma Limited (9969.HK) Income Statement Analysis – Financial Results
- Kaynes Technology India Limited (KAYNES.NS) Income Statement Analysis – Financial Results
- E&E Recycling,Inc. (8440.TWO) Income Statement Analysis – Financial Results
Global Medical REIT Inc. (GMRE)
About Global Medical REIT Inc.
Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 140.93M | 137.28M | 115.94M | 93.73M | 70.73M | 53.19M | 30.22M | 8.08M | 2.06M | 380.41K | 0.00 | 0.00 |
Cost of Revenue | 86.22M | 25.19M | 15.49M | 10.87M | 5.96M | 3.72M | 1.86M | 1.43M | 1.02M | 360.00K | 0.00 | 0.00 |
Gross Profit | 54.72M | 112.10M | 100.45M | 82.86M | 64.77M | 49.47M | 28.36M | 6.65M | 1.04M | 20.41K | 0.00 | 0.00 |
Gross Profit Ratio | 38.82% | 81.65% | 86.64% | 88.41% | 91.58% | 93.01% | 93.85% | 82.25% | 50.54% | 5.36% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.15 | 0.17 | -0.03 | 0.14 | 0.27 | 0.00 | -0.77 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 16.85M | 16.55M | 16.45M | 29.96M | 12.80M | 9.96M | 8.61M | 5.73M | 865.14K | 604.87K | 45.34K | 50.11K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 16.85M | 16.55M | 16.45M | 29.96M | 12.80M | 9.96M | 8.61M | 5.73M | 865.14K | 604.87K | 45.34K | 50.11K |
Other Expenses | 0.00 | 56.72M | 46.88M | 36.35M | 24.64M | 17.27M | 121.00K | 130.78K | 659.67K | 129.08K | 0.00 | 0.00 |
Operating Expenses | 16.90M | 73.27M | 63.33M | 66.32M | 37.44M | 27.23M | 18.61M | 8.10M | 1.52M | 733.95K | 45.34K | 50.11K |
Cost & Expenses | 103.11M | 98.46M | 78.82M | 77.18M | 43.40M | 30.95M | 20.47M | 8.10M | 1.52M | 733.95K | 45.34K | 50.11K |
Interest Income | 0.00 | 25.23M | 19.70M | 18.68M | 17.47M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 30.89M | 25.23M | 19.70M | 18.68M | 17.47M | 14.98M | 7.44M | 4.14M | 1.52M | 298.66K | 0.00 | 0.00 |
Depreciation & Amortization | 59.01M | 98.81M | 78.97M | 77.51M | 43.70M | 31.33M | 23.00M | 10.43M | 659.67K | 129.08K | 0.00 | 50.11K |
EBITDA | 111.64M | 96.49M | 84.00M | 53.00M | 50.82M | 40.20M | 17.35M | 2.48M | 569.53K | -224.46K | -45.34K | 0.00 |
EBITDA Ratio | 79.21% | 70.28% | 72.45% | 56.44% | 73.48% | 75.58% | 66.18% | 30.75% | 58.04% | -59.01% | 0.00% | 0.00% |
Operating Income | 37.94M | 38.83M | 37.12M | 16.55M | 27.33M | 22.24M | 7.35M | -2.21M | -1.52M | -652.21K | -45.34K | -50.11K |
Operating Income Ratio | 26.92% | 28.28% | 32.02% | 17.65% | 38.64% | 41.82% | 24.31% | -27.41% | -73.96% | -171.45% | 0.00% | 0.00% |
Total Other Income/Expenses | -16.20M | -18.83M | -18.78M | -30.77M | -17.47M | -7.68M | -9.96M | -6.33M | -2.13M | 0.00 | 0.00 | 0.00 |
Income Before Tax | 21.73M | 20.00M | 18.34M | -2.50M | 9.59M | 14.56M | -87.00K | -6.35M | -1.61M | -652.21K | -45.34K | -50.11K |
Income Before Tax Ratio | 15.42% | 14.57% | 15.82% | -2.67% | 13.56% | 27.37% | -0.29% | -78.64% | -78.06% | -171.45% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 25.23M | 20.42M | 18.11M | 17.83M | 1.07M | -49.00K | 4.27M | 1.52M | 597.33K | 0.00 | 50.11K |
Net Income | 20.61M | -5.23M | -2.07M | -20.61M | -8.24M | 13.49M | -38.00K | -6.35M | -1.61M | -652.21K | -45.34K | -50.11K |
Net Income Ratio | 14.63% | -3.81% | -1.79% | -21.98% | -11.65% | 25.36% | -0.13% | -78.64% | -78.06% | -171.45% | 0.00% | 0.00% |
EPS | 0.23 | -0.08 | -0.03 | -0.45 | -0.24 | 0.61 | 0.00 | -0.68 | -6.44 | -13.49 | -2.32 | -2.51 |
EPS Diluted | 0.23 | -0.08 | -0.03 | -0.45 | -0.24 | 0.61 | 0.00 | -0.68 | -6.44 | -13.49 | -2.32 | -2.51 |
Weighted Avg Shares Out | 65.55M | 65.46M | 60.64M | 46.26M | 33.87M | 21.97M | 19.62M | 9.30M | 250.00K | 48.36K | 19.57K | 20.00K |
Weighted Avg Shares Out (Dil) | 65.55M | 65.46M | 60.64M | 46.26M | 33.87M | 21.97M | 19.62M | 9.30M | 250.00K | 48.36K | 19.57K | 20.00K |
Fed Goes Big
GMRE or CDP: Which Is the Better Value Stock Right Now?
Global Medical REIT Inc. Board Declares 2024 Third Quarter Common and Preferred Dividends
I Sold These REITs
GMRE vs. CDP: Which Stock Is the Better Value Option?
Two 9% Yielding REITs, Where It's Worth Waiting A Bit Before Buying
Want $13,500? Check Out These High Dividend REIT Stocks
Slate Grocery REIT: Still A Hold Until The Inflection Point Later This Year
Global Medical: Steward Issues Could Force Dividend Cut
Global Medical REIT: Stability Across The Board, But More Is Needed To Be Bullish
Source: https://incomestatements.info
Category: Stock Reports